Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
NCT00002746
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
Interventions
BIOLOGICAL:
aldesleukin
Sponsor
University of Washington